Ramalingam, S. S., Belani, C. P., Mack, P. C., Vokes, E. E., Longmate, J., Govindan, R., . . . Gandara, D. R. (2010). Phase II study of cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (NCI # 7097).

Ramalingam, Suresh S., Chandra P. Belani, Philip C. Mack, Everett E. Vokes, Jeffrey Longmate, Ramaswamy Govindan, Marianna Koczywas, S. Percy Ivy, و David R. Gandara. Phase II Study of Cediranib (AZD 2171), an Inhibitor of the Vascular Endothelial Growth Factor Receptor, for Second-line Therapy of Small Cell Lung Cancer (NCI # 7097). 2010.

Ramalingam, Suresh S., et al. Phase II Study of Cediranib (AZD 2171), an Inhibitor of the Vascular Endothelial Growth Factor Receptor, for Second-line Therapy of Small Cell Lung Cancer (NCI # 7097). 2010.